BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8661104)

  • 1. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22.
    MacGrogan D; Levy A; Bova GS; Isaacs WB; Bookstein R
    Genomics; 1996 Jul; 35(1):55-65. PubMed ID: 8661104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation in multiple human cancers of a novel gene, DMHC, from 17q25.1 that encodes an integral membrane protein.
    Mikami I; Harada H; Nagai H; Tsuneizumi M; Nobe Y; Koizumi K; Sugano S; Tanaka S; Emi M
    Jpn J Cancer Res; 2001 Apr; 92(4):417-22. PubMed ID: 11346464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic in silico discovery of novel solute carrier-like proteins from proteomes.
    Gyimesi G; Hediger MA
    PLoS One; 2022; 17(7):e0271062. PubMed ID: 35901096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Sisters From Qatar With TUSC3 Genetic Mutation: Psychiatric Considerations.
    Albobali Y; Shahwan MY; Madi MY; Al-Nuaimi S
    Cureus; 2021 Aug; 13(8):e17616. PubMed ID: 34646667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidoreductases in Glycoprotein Glycosylation, Folding, and ERAD.
    Patel C; Saad H; Shenkman M; Lederkremer GZ
    Cells; 2020 Sep; 9(9):. PubMed ID: 32971745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-145: a potential biomarker of cancer migration and invasion.
    Xu WX; Liu Z; Deng F; Wang DD; Li XW; Tian T; Zhang J; Tang JH
    Am J Transl Res; 2019; 11(11):6739-6753. PubMed ID: 31814885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligosaccharyltransferase: A Gatekeeper of Health and Tumor Progression.
    Harada Y; Ohkawa Y; Kizuka Y; Taniguchi N
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium transporter 1 (MAGT1) deficiency causes selective defects in
    Matsuda-Lennikov M; Biancalana M; Zou J; Ravell JC; Zheng L; Kanellopoulou C; Jiang P; Notarangelo G; Jing H; Masutani E; Oler AJ; Olano LR; Schulz BL; Lenardo MJ
    J Biol Chem; 2019 Sep; 294(37):13638-13656. PubMed ID: 31337704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC.
    Jeon YJ; Kim T; Park D; Nuovo GJ; Rhee S; Joshi P; Lee BK; Jeong J; Suh SS; Grotzke JE; Kim SH; Song J; Sim H; Kim Y; Peng Y; Jeong Y; Garofalo M; Zanesi N; Kim J; Liang G; Nakano I; Cresswell P; Nana-Sinkam P; Cui R; Croce CM
    Nat Commun; 2018 Nov; 9(1):5110. PubMed ID: 30504895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and Clinicopathological Value of
    Liang H; Xiong Z; Li Y; Kong W; Yao Z; Li R; Deng M; Hu K
    Biomed Res Int; 2018; 2018():4621015. PubMed ID: 30079348
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor suppressor candidate 3: A novel grading tool and predictor of clinical malignancy in human gliomas.
    Yuan J; Yu X; Wang A; Li Y; Liu F; Wang Y; Sun S; Bing X; Liu Y; Du J
    Oncol Lett; 2018 Apr; 15(4):5655-5661. PubMed ID: 29556302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.
    Sheng XR; Xing SG; Wang RD; Chen K; Jia WD
    Onco Targets Ther; 2018; 11():909-917. PubMed ID: 29503566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUSC3: functional duality of a cancer gene.
    Vašíčková K; Horak P; Vaňhara P
    Cell Mol Life Sci; 2018 Mar; 75(5):849-857. PubMed ID: 28929175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TUSC3: a novel tumour suppressor gene and its functional implications.
    Yu X; Zhai C; Fan Y; Zhang J; Liang N; Liu F; Cao L; Wang J; Du J
    J Cell Mol Med; 2017 Sep; 21(9):1711-1718. PubMed ID: 28272772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor candidate 3 as a novel predictor for lymph node metastasis in lung cancer patients.
    Yu X; Zhang K; Liu F; Zhang J; Zhai C; Cao L; Song X; Wang Y; Li B; Sun H; Du J
    Oncol Lett; 2016 Dec; 12(6):5099-5105. PubMed ID: 28105217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
    Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
    Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.
    Jiang Z; Guo M; Zhang X; Yao L; Shen J; Ma G; Liu L; Zhao L; Xie C; Liang H; Wang H; Zhu M; Hu L; Song Y; Shen H; Lin Z
    Tumour Biol; 2016 Sep; 37(9):12039-12047. PubMed ID: 27177902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-linked glycosylation and homeostasis of the endoplasmic reticulum.
    Cherepanova N; Shrimal S; Gilmore R
    Curr Opin Cell Biol; 2016 Aug; 41():57-65. PubMed ID: 27085638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins.
    Cherepanova NA; Shrimal S; Gilmore R
    J Cell Biol; 2014 Aug; 206(4):525-39. PubMed ID: 25135935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.